Director sold
~$34.6MReported value · 370K sh @ $93.4482
Stock since the trade -6.8% · S&P 500 +4.3% · to Oct 5
A board member of CVS Health sold $34.6M of CVS Health shares. Nobody planned it ahead of time.
Loading…
Reporting person on SEC Form 4
Larry Robbins
Larry Robbins is Director at CVS Health. OQRO lists 10 transactions filed with the SEC under this name, the latest on May 21, 2026, each linked to the official Form 4.
Director
Disclosures on record
10
Companies involved
1
Disclosure history
Director sold
~$35.3MReported value · 378K sh @ $93.311
Stock since the trade -6.8% · S&P 500 +4.3% · to Oct 5
A board member of CVS Health sold $35.3M of CVS Health shares. Nobody planned it ahead of time.
Director sold
~$74.6MReported value · 798K sh @ $93.4766
Stock since the trade -6.7% · S&P 500 +4.5% · to Oct 5
A board member of CVS Health sold $74.6M of CVS Health shares. Nobody planned it ahead of time.
Director sold
~$14.5MReported value · 153K sh @ $94.8061
Stock since the trade -6.7% · S&P 500 +4.5% · to Oct 5
A board member of CVS Health sold $14.5M of CVS Health shares. Nobody planned it ahead of time.
Director sold
~$187MReported value · 1.98M sh @ $94.448
Stock since the trade -7.6% · S&P 500 +5.6% · to Oct 5
A board member of CVS Health sold $187M of CVS Health shares. Nobody planned it ahead of time.
Director sold
~$6.4MReported value · 67K sh @ $95.6655
Stock since the trade -6.7% · S&P 500 +4.5% · to Oct 5
A board member of CVS Health sold $6.4M of CVS Health shares. Nobody planned it ahead of time.
Director sold
~$77KReported value · 800 sh @ $96.2819
Stock since the trade -6.7% · S&P 500 +4.5% · to Oct 5
A board member of CVS Health sold $77K of CVS Health shares. Nobody planned it ahead of time.
Director sold
~$14KReported value · 151 sh @ $95.18
Stock since the trade -7.6% · S&P 500 +5.6% · to Oct 5
A board member of CVS Health sold $14K of CVS Health shares. Nobody planned it ahead of time.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.